Beneficial effects of granulocyte-colony stimulating factor on small-diameter heparin immobilized decellularized vascular graft

Journal of Biomedical Materials Research - Part A

Volumn 95 A, Issue 2, 2010, Pages 600-610

  Zhou, Min ^a   Liu, Zhao ^a   Li, Kun ^a   Qiao, Wei ^a   Jiang, Xuefeng ^b   Ran, Feng ^a   Qiao, Tong ^a   Liu, Changjian ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

decellularized; endothelialization; granulocyte colony stimulating factor; neointimal hyperplasia; small diameter

Indexed keywords

DECELLULARIZED; ENDOTHELIALIZATION; GRANULOCYTE-COLONY STIMULATING FACTOR; NEOINTIMAL HYPERPLASIA; SMALL-DIAMETER;

ANIMALS; ENDOTHELIAL CELLS; POLYSACCHARIDES; RATS; SELF ASSEMBLY;

GRAFTS;

CD133 ANTIGEN; HEPARIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL SHUNT; CD34 SELECTION; CELL SPECIFICITY; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG RELEASE; DRUG STABILITY; ENDOTHELIUM CELL; GRAFT PATENCY; HEART VENTRICLE HYPERTROPHY; HEPARINIZATION; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; INTIMA; NANOFABRICATION; NEOINTIMAL HYPERPLASIA; NONHUMAN; RAT; STEM CELL; SURGICAL TECHNIQUE; VEIN THROMBOSIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; ENDOTHELIAL CELLS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEPARIN; IMPLANTS, EXPERIMENTAL; MATERIALS TESTING; PLATELET ADHESIVENESS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TISSUE SCAFFOLDS; TUNICA INTIMA;

EID: 78649302457     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32864     Document Type: Article

References (29)

1. Sales KM, Salacinski HJ, Alobaid N, Mikhail M, Balakrishnan V, Seifalian AM,. Advancing vascular tissue engineering: The role of stem cell technology. Trends Biotechnol 2005; 23: 461-467.
2. Chandiwal A, Balasubramanian V, Baldwin ZK, Conte MS, Schwartz LB,. Gene therapy for the extension of vein graft patency: A review. Vascular Endovascular Surgery 2005; 39 (1): 1-14.
3. Kakisis JD, Liapis CD, Breuer C, Sumpio BE,. Artificial blood vessel: The Holy Grail of peripheral vascular surgery. J Vasc Surg 2005; 41: 349-354.
4. Roy S, Silacci P, Stergiopulos N,. Biomechanical properties of decellularized porcine common carotid arteries. Am J Physiol Heart Circ Physiol 2005; 289: H1567-H1576.
5. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE Jr., Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-1040.
6. Cho SW, Lim SH, Kim IK, Hong YS, Kim SS, Yoo KJ, Park HY, Jang Y, Chang BC, Choi CY, Hwang KC, Kim BS,. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005; 241: 506-515.
7. Amiel GE, Komura M, Shapira O, Yoo JJ, Yazdani S, Berry J, Kaushal S, Bischoff J, Atala A, Soker S,. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng 2006; 12: 2355-2365.
8. Cho SW, Lim JE, Chu HS, Hyun HJ, Choi CY, Hwang KC, Yoo KJ, Kim DI, Kim BS,. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. J Biomed Mater Res A 2006; 76: 252-263.
9. Randone B, Cavallaro G, Polistena A, Cucina A, Coluccia P, Graziano P, Cavallaro A,. Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J Surg Res 2005; 127: 70-79.
10. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP,. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
11. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP,. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-77.
12. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S,. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
13. Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J, Hwang KK, Oh S, Choi YJ, Chae IH, Oh BH, Choi YS, Walsh K, Park YB,. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003; 108: 2918-2925.
14. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE, Dzau VJ,. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110: 2039-2046.
15. Takamiya M, Okigaki M, Jin D, Takai S, Nozawa Y, Adachi Y, Urao N, Tateishi K, Nomura T, Zen K, Ashihara E, Miyazaki M, Tatsumi T, Takahashi T, Matsubara H,. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2006; 26: 751-757.
16. Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, Izawa A, Ise H, Ikeda U,. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 2006; 70: 61-69.
17. Shoji M, Iso Y, Kusuyama T, Omori Y, Soda T, Tsunoda F, Sato T, Koba S, Geshi E, Kobayashi Y, Katagiri T, Suzuki H,. High-dose granulocyte-colony stimulating factor promotes neointimal hyperplasia in the early phase and inhibits neointimal hyperplasia in the late phase after vascular injury. Circ J 2008; 72: 1885-1893.
18. Bhattacharya V, Shi Q, Ishida A, Sauvage LR, Hammond WP, Wu MH,. Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in small-caliber synthetic vascular grafts. J Vasc Surg 2000; 32: 116-123.
19. Shi Q, Bhattacharya V, Hong-De Wu M, Sauvage LR,. Utilizing granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells. Ann Vasc Surg 2002; 16: 314-320.
20. Yao C, Roderfeld M, Rath T, Roeb E, Bernhagen J, Steffens G,. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials 2006; 27: 1608-1616.
21. Wissink MJ, Beernink R, Pieper JS, Poot AA, Engbers GH, Beugeling T, van Aken WG, Feijen J,. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 2001; 22: 151-163.
22. Tsai CC, Chang Y, Sung HW, Hsu JC, Chen CN,. Effects of heparin immobilization on the surface characteristics of a biological tissue fixed with a naturally occurring crosslinking agent (genipin): An in vitro study. Biomaterials 2001; 22: 523-533.
23. Spiller D, Losi P, Briganti E, Sbrana S, Kull S, Martinelli I, Soldani G,. PDMS content affects in vitro hemocompatibility of synthetic vascular grafts. J Mater Sci Mater Med 2007; 18: 1097-1104.
24. Walles T, Herden T, Haverich A, Mertsching H,. Influence of scaffold thickness and scaffold composition on bioartificial graft survival. Biomaterials 2003; 24: 1233-1239
25. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C,. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002; 24: 173-183.
26. Wang XN, Chen CZ, Yang M, Gu YJ,. Implantation of decellularized small-caliber vascular xenografts with and without surface heparin treatment. Artif Organs 2007; 31: 99-104.
27. Liao D, Wang X, Lin PH, Yao Q, Chen CJ,. Covalent linkage of heparin provides a stable anti-coagulation surface of decellularized porcine arteries. J Cell Mol Med 2009; 13: 2736-2743.
28. Azoulay E, Attalah H, Yang K, Jouault H, Schlemmer B, Brun-Buisson C, Brochard L, Harf A, Delclaux C,. Exacerbation by granulocyte colony stimulating factor of prior acute lung injury: Implication of neutrophils. Crit Care Med 2002; 30: 2115-2122.
29. Valgimigli M, Rigolin GM, Cittanti C, Malagutti P, Curello S, Percoco G, Bugli AM, Della Porta M, Bragotti LZ, Ansani L, Mauro E, Lanfranchi A, Giganti M, Feggi L, Castoldi G, Ferrari R,. Use of granulocyte-colony stimulating factor during AMI to enhance BM stem cell mobilization in humans: Clinical and angiographic safety profile. Eur Heart J 2005; 26: 1838-1845.